Advertisement

Index by author

August 01, 1989; Volume 250,Issue 2

A

  1. Acad, B A

    1. Regional O2 consumption and coronary flow during beta adrenoceptor stimulation in reperfused canine myocardium.
      B A Acad and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 611-616;

  2. Amrick, C L

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

  3. Anderson, D

    1. Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;

  4. Antonelli, T

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

B

  1. Bäärnhielm, C

    1. Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;

  2. Balduini, W

    1. Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development.
      W Balduini and L G Costa
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 541-547;

  3. Barnett, A

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

  4. Beani, L

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

  5. Bennett, D A

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

  6. Bernard, P S

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

  7. Besseghir, K

    1. Transport of methotrexate by the in vitro isolated rabbit proximal tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 688-695;

  8. Bianchi, C

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

  9. Bigelow, G E

    1. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;

  10. Bonanno, G

    1. Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
      M Raiteri, G Bonanno and E Fedele
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 648-653;

  11. Bousquet, P

    1. Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;

  12. Brown, K E

    1. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;

C

  1. Chiba, S

    1. Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
      A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;

  2. Chiorazzi, N

    1. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

  3. Chiu, P J

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

  4. Cho, A K

    1. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;

  5. Choi, D W

    1. Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture.
      D M Hartley and D W Choi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 752-758;

  6. Clay, K L

    1. Role of brain tyrosine availability in mediating differences in ethanol sensitivity in long-sleep and short-sleep mice.
      T A French, K L Clay and N Weiner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 556-564;

  7. Costa, L G

    1. Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development.
      W Balduini and L G Costa
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 541-547;

  8. Croxson, T S

    1. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

D

  1. Daly, R N

    1. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
      J P Hieble, J G Duesler and R N Daly
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 523-528;

  2. Derse, C P

    1. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;

  3. Descatoire, V

    1. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;

  4. Dewar, K M

    1. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
      K M Dewar, B Montreuil, L Grondin and T A Reader
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;

  5. Donati, D

    1. Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
      K G Mugridge, D Donati, S Silvestri and L Parente
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;

  6. Drapeau, G

    1. Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;

  7. Drewett, J G

    1. Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler, G R Marchand and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;

  8. Duesler, J G

    1. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
      J P Hieble, J G Duesler and R N Daly
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 523-528;

  9. Duncia, J V

    1. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;

E

  1. Eberle, N B

    1. A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

  2. el-Fakahany, E E

    1. Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;

  3. Endou, M

    1. Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
      M Endou, Y Hattori, H Nakaya and M Kanno
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;

F

  1. Fedele, E

    1. Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
      M Raiteri, G Bonanno and E Fedele
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 648-653;

  2. Feldman, J

    1. Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;

  3. Flynn, D D

    1. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
      D D Flynn and D C Mash
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 573-581;

  4. Forray, C

    1. Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;

  5. Foster, C J

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

  6. Freeland, H S

    1. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;

  7. French, T A

    1. Role of brain tyrosine availability in mediating differences in ethanol sensitivity in long-sleep and short-sleep mice.
      T A French, K L Clay and N Weiner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 556-564;

  8. Frenken, M

    1. Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
      M Frenken and A J Kaumann
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 707-713;

G

  1. George, R

    1. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;

  2. Gertner, S B

    1. Studies on the cardiovascular actions of central histamine H1 and H2 receptors.
      J J Poulakos and S B Gertner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 500-507;

  3. Ghali, V

    1. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

  4. Glick, S D

    1. A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

  5. Gogas, K R

    1. A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

  6. Gonon, F

    1. Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;

  7. Grøn, P

    1. Skeletal muscle Na,K-pump concentration in children and its relationship to cardiac glycoside distribution.
      K Kjeldsen and P Grøn
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 721-725;

  8. Grondin, L

    1. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
      K M Dewar, B Montreuil, L Grondin and T A Reader
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;

H

  1. Harf, A

    1. Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
      I Macquin-Mavier, M Levame, N Istin and A Harf
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;

  2. Hartley, D M

    1. Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture.
      D M Hartley and D W Choi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 752-758;

  3. Haslanger, M F

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

  4. Hattori, Y

    1. Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
      M Endou, Y Hattori, H Nakaya and M Kanno
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;

  5. Hay, D W

    1. Cellular mechanisms of endothelin in rabbit aorta.
      E H Ohlstein, S Horohonich and D W Hay
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 548-555;

  6. Heishman, S J

    1. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;

  7. Hieble, J P

    1. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation.
      J P Hieble, J G Duesler and R N Daly
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 523-528;

  8. Hiramatsu, M

    1. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;

  9. Ho, B Y

    1. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
      B Y Ho and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 508-514;

  10. Holycross, B J

    1. Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
      B J Holycross and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 433-441;
    2. Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
      B J Holycross, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 442-453;

  11. Horiuchi, A

    1. Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
      A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;

  12. Horohonich, S

    1. Cellular mechanisms of endothelin in rabbit aorta.
      E H Ohlstein, S Horohonich and D W Hay
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 548-555;

  13. Hough, L B

    1. A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

  14. Hutchison, A J

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

I

  1. Istin, N

    1. Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
      I Macquin-Mavier, M Levame, N Istin and A Harf
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;

  2. Itoh, T

    1. Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.
      T Shimizu, T Itoh and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 659-666;
    2. Hepatoprotective effects of cystathionine against acetaminophen-induced necrosis.
      Y Kitamura, Y Kamisaki and T Itoh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 667-671;

  3. Iwatsuki, K

    1. Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
      A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;

J

  1. Jackson, E K

    1. Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
      B J Holycross and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 433-441;
    2. Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
      B J Holycross, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 442-453;

  2. Jones, A W

    1. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
      J M Post, J M Smith and A W Jones
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 591-597;

K

  1. Kalsner, S

    1. Nonneurogenic relaxation to field stimulation in coronary arteries.
      S Kalsner and M Quillan
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 461-469;

  2. Kamisaki, Y

    1. Hepatoprotective effects of cystathionine against acetaminophen-induced necrosis.
      Y Kitamura, Y Kamisaki and T Itoh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 667-671;

  3. Kanno, M

    1. Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
      M Endou, Y Hattori, H Nakaya and M Kanno
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;

  4. Kaumann, A J

    1. Dimethylation of the activator ICI 169,369 results in a high-affinity partial deactivator, ICI 170,809, of the arterial 5-hydroxytryptamine2 receptor system.
      M Frenken and A J Kaumann
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 707-713;

  5. King, A G

    1. Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation.
      A G King, K S Landreth and D Wierda
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 582-590;

  6. Kitamura, Y

    1. Hepatoprotective effects of cystathionine against acetaminophen-induced necrosis.
      Y Kitamura, Y Kamisaki and T Itoh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 667-671;

  7. Kjeldsen, K

    1. Skeletal muscle Na,K-pump concentration in children and its relationship to cardiac glycoside distribution.
      K Kjeldsen and P Grøn
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 721-725;

  8. Kreek, M J

    1. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

  9. Kurtzman, N A

    1. Vanadate stimulates the N-ethylmaleimide-sensitive adenosine triphosphatase in rat nephron.
      S Sabatini and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 529-533;

L

  1. Labbe, G

    1. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;

  2. Landreth, K S

    1. Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation.
      A G King, K S Landreth and D Wierda
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 582-590;

  3. Larrey, D

    1. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;

  4. Leighton, H J

    1. Analysis of the presence of postjunctional alpha-2 adrenoceptors in the rat anococcygeus muscle.
      M V Ramagopal and H J Leighton
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 492-499;

  5. Lemasters, J J

    1. Role of purines and xanthine oxidase in reperfusion injury in perfused rat liver.
      Z Zhong, J J Lemasters and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 470-475;

  6. Letteron, P

    1. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;

  7. Levame, M

    1. Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
      I Macquin-Mavier, M Levame, N Istin and A Harf
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;

  8. Li, P

    1. Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
      B J Holycross, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 442-453;

  9. Liebman, J M

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

  10. Liebson, I A

    1. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;

  11. Loeper, J

    1. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;

  12. Lyon, R A

    1. A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

M

  1. Macquin-Mavier, I

    1. Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig.
      I Macquin-Mavier, M Levame, N Istin and A Harf
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 740-745;

  2. Maggi, C A

    1. Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;

  3. Marchand, G R

    1. Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler, G R Marchand and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;

  4. Mash, D C

    1. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
      D D Flynn and D C Mash
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 573-581;

  5. McKinney, M

    1. Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;

  6. Meli, A

    1. Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;

  7. Mercer, W D

    1. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

  8. Mermet, C

    1. Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;

  9. Miyata, K

    1. Effect of S-8666 on urinary Ca++ excretion in rats.
      T Shimizu, K Miyata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 654-658;

  10. Montreuil, B

    1. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
      K M Dewar, B Montreuil, L Grondin and T A Reader
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;

  11. Mosig, D

    1. Transport of methotrexate by the in vitro isolated rabbit proximal tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 688-695;

  12. Mugridge, K G

    1. Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
      K G Mugridge, D Donati, S Silvestri and L Parente
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;

N

  1. Nakamura, M

    1. Effect of S-8666 on urinary Ca++ excretion in rats.
      T Shimizu, K Miyata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 654-658;
    2. Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.
      T Shimizu, T Itoh and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 659-666;

  2. Nakaya, H

    1. Differential effects of somatostatin on atrial and ventricular contractile responses in guinea pig heart: influence of pretreatment with islet-activating protein.
      M Endou, Y Hattori, H Nakaya and M Kanno
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 726-733;

  3. Novick, D M

    1. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

O

  1. Ochshorn, M

    1. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
      D M Novick, M Ochshorn, V Ghali, T S Croxson, W D Mercer, N Chiorazzi and M J Kreek
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 606-610;

  2. Ohlstein, E H

    1. Cellular mechanisms of endothelin in rabbit aorta.
      E H Ohlstein, S Horohonich and D W Hay
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 548-555;

P

  1. Parente, L

    1. Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
      K G Mugridge, D Donati, S Silvestri and L Parente
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;

  2. Parini, A

    1. Adrenergic agonists and the Na+-K+-adenosine triphosphatase from rabbit proximal tubules and their basolateral membranes.
      R A Podevin and A Parini
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 672-677;

  3. Parsons, M E

    1. A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

  4. Patacchini, R

    1. Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;

  5. Pechnick, R N

    1. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;

  6. Pessayre, D

    1. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;

  7. Peters, S P

    1. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;

  8. Pitts, B

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

  9. Podevin, R A

    1. Adrenergic agonists and the Na+-K+-adenosine triphosphatase from rabbit proximal tubules and their basolateral membranes.
      R A Podevin and A Parini
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 672-677;

  10. Poland, R E

    1. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance.
      R N Pechnick, R George, R E Poland, M Hiramatsu and A K Cho
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 534-540;

  11. Post, J M

    1. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
      J M Post, J M Smith and A W Jones
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 591-597;

  12. Poulakos, J J

    1. Studies on the cardiovascular actions of central histamine H1 and H2 receptors.
      J J Poulakos and S B Gertner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 500-507;

  13. Price, W A

    1. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;

Q

  1. Quillan, M

    1. Nonneurogenic relaxation to field stimulation in coronary arteries.
      S Kalsner and M Quillan
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 461-469;

R

  1. Raiteri, M

    1. Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors.
      M Raiteri, G Bonanno and E Fedele
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 648-653;

  2. Ramagopal, M V

    1. Analysis of the presence of postjunctional alpha-2 adrenoceptors in the rat anococcygeus muscle.
      M V Ramagopal and H J Leighton
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 492-499;

  3. Reader, T A

    1. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
      K M Dewar, B Montreuil, L Grondin and T A Reader
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 696-706;

  4. Regårdh, C G

    1. Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;

  5. Regoli, D

    1. Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;

  6. Reilly, T M

    1. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;

  7. Roch-Ramel, F

    1. Transport of methotrexate by the in vitro isolated rabbit proximal tubule.
      K Besseghir, D Mosig and F Roch-Ramel
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 688-695;

  8. Rovero, P

    1. Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
      R Patacchini, C A Maggi, P Rovero, D Regoli, G Drapeau and A Meli
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 678-681;

S

  1. Sabatini, S

    1. Vanadate stimulates the N-ethylmaleimide-sensitive adenosine triphosphatase in rat nephron.
      S Sabatini and N A Kurtzman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 529-533;

  2. Schleimer, R P

    1. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
      R P Schleimer, H S Freeland, S P Peters, K E Brown and C P Derse
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 598-605;

  3. Shimizu, T

    1. Effect of S-8666 on urinary Ca++ excretion in rats.
      T Shimizu, K Miyata and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 654-658;
    2. Additive diuretic effect of S-8666 during furosemide-induced diuresis in rats.
      T Shimizu, T Itoh and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 659-666;

  4. Silvestri, S

    1. Arachidonic acid lipoxygenation may be involved in interleukin-1 induction of prostaglandin biosynthesis.
      K G Mugridge, D Donati, S Silvestri and L Parente
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 714-720;

  5. Simonato, M

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

  6. Smith, J M

    1. BRL 34915 (Cromakalim) stimulation of 42K efflux from rabbit arteries is modulated by calcium.
      J M Post, J M Smith and A W Jones
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 591-597;

  7. Spalluto, P

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

  8. Stitzer, M L

    1. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
      S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 485-491;

  9. Sutfin, T A

    1. Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;

  10. Sybertz, E J

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

T

  1. Takemori, A E

    1. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
      B Y Ho and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 508-514;

  2. Tanganelli, S

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

  3. Thurman, R G

    1. Role of purines and xanthine oxidase in reperfusion injury in perfused rat liver.
      Z Zhong, J J Lemasters and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 470-475;

  4. Tibirica, E

    1. Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.
      E Tibirica, C Mermet, J Feldman, F Gonon and P Bousquet
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 642-647;

  5. Timmermans, P B

    1. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;

  6. Tinel, M

    1. Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
      M Tinel, V Descatoire, D Larrey, J Loeper, G Labbe, P Letteron and D Pessayre
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 746-751;

  7. Tomasini, C

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

  8. Trachte, G J

    1. Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler, G R Marchand and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;

V

  1. Vemulapalli, S

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

W

  1. Wang, S X

    1. Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;

  2. Ward, S J

    1. A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

  3. Watkins, J B

    1. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
      J B Watkins
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 421-427;

  4. Watkins, R W

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

  5. Weiler, M H

    1. Muscarinic modulation of endogenous acetylcholine release in rat neostriatal slices.
      M H Weiler
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 617-623;

  6. Weiner, N

    1. Role of brain tyrosine availability in mediating differences in ethanol sensitivity in long-sleep and short-sleep mice.
      T A French, K L Clay and N Weiner
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 556-564;

  7. Weiss, H R

    1. Regional O2 consumption and coronary flow during beta adrenoceptor stimulation in reperfused canine myocardium.
      B A Acad and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 611-616;

  8. Wierda, D

    1. Bone marrow stromal cell regulation of B-lymphopoiesis. II. Mechanisms of hydroquinone inhibition of pre-B cell maturation.
      A G King, K S Landreth and D Wierda
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 582-590;

  9. Wilson, D E

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

  10. Wong, P C

    1. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody.
      P C Wong, W A Price, T M Reilly, J V Duncia and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 515-522;

Y

  1. Yonekura, H

    1. Do D-1 dopamine receptors mediate dopamine-induced pancreatic exocrine secretion in anesthetized dogs?
      A Horiuchi, K Iwatsuki, H Yonekura and S Chiba
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 734-739;

  2. Yoshioka, M

    1. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
      M Yoshioka
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 637-641;

  3. Young, R C

    1. A role for histamine and H2-receptors in opioid antinociception.
      K R Gogas, L B Hough, N B Eberle, R A Lyon, S D Glick, S J Ward, R C Young and M E Parsons
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 476-484;

Z

  1. Zhong, Z

    1. Role of purines and xanthine oxidase in reperfusion injury in perfused rat liver.
      Z Zhong, J J Lemasters and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 470-475;

  2. Ziegler, R J

    1. Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
      J G Drewett, R J Ziegler, G R Marchand and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 428-432;
Back to top

In this issue